MedSpark

MedSpark

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MedSpark operates as a service-based medical product design and development firm, acting as a strategic partner for clinicians and medical professionals with innovative product ideas. The company leverages a structured process integrating research, engineering, and industrial design to de-risk and advance client concepts toward commercialization, including support for regulatory pathways like FDA 510(k) and ISO 13485. Founded in 2018, it is a private company that appears to be in an early-revenue stage, generating income from client development contracts rather than selling its own proprietary products. Its value proposition centers on accelerating innovation by providing the technical and regulatory expertise that individual inventors or small companies often lack.

Medical DevicesDrug Delivery

Technology Platform

Integrated medical product development process combining research, engineering, industrial design, IP strategy, prototyping, regulatory testing, and project management.

Opportunities

The large and growing global medical device market, coupled with a constant stream of ideas from medical professionals lacking development resources, presents a significant client base.
Positioning as an end-to-end, regulatory-savvy development partner in the major biotech hub of San Diego allows access to a dense network of innovators.

Risk Factors

Revenue is entirely dependent on winning client projects in a competitive service market.
Execution risks include technical failures, regulatory setbacks on client projects, and potential IP disputes.
The business is highly reliant on the expertise and networks of its two co-founders.

Competitive Landscape

Competes with other medical device design firms, independent engineering consultants, and potentially in-house R&D teams at larger medtech companies. Differentiation is achieved through a comprehensive, integrated service offering that includes strong regulatory strategy and a focus on guiding clients from idea to divestiture.